Name: Li Xun
Title: Chief Physician
Title: Professor, Master's Degree Supervisor
Detailed introduction:
Excellent Expert of Guangzhou in 1995, Expert with Outstanding Contributions of Guangdong Province in 1998, Young and Middle-aged Expert with Outstanding Contributions of the Ministry of Health in 2006, and enjoying the State Council's special governmental allowance. Currently, he is the president and director of minimally invasive surgery of Harbor Hospital of Guangzhou Medical College, and senior expert of Minimally Invasive Surgery Center of Haiyin Branch of the First Affiliated Hospital of Guangzhou Medical College. He is a national member of the Chinese Medical Association Urology Branch and a member of the Intracavernous Urology Group, a vice-chairman of the Urology Society of the Guangdong Medical Association, a standing committee member of the Minimally Invasive Surgery Society of the Guangdong Medical Association and a leader of the urology group, and an executive director of the Guangzhou Medical Association and a vice-chairman of the Urology Society. He serves as an editorial board member of Chinese Journal of Urology, Chinese Journal of Minimally Invasive Surgery, Journal of Clinical Urology, Journal of Modern Urology, Journal of Modern Clinical Medical Bioengineering, and Journal of Guangzhou Medical College. In 2006, he was awarded the "Golden Cystoscope Award", the highest honorary award in domestic endoluminal urology, the 16th "Endoscopy" International Endoscopy Award - Urology Award, and many times won the national, provincial, ministerial, and municipal scientific and technological achievement awards. He is the chief editor of Minimally Invasive Urological Surgery, and participated in the writing of Urological Surgery, Urological Stones, Urological Endoscopy Diagnosis and Treatment, Prevention and Treatment of Urological Surgical Complications, Urological Surgeon's Required Readings for Further Training, and China's Guide to Diagnosis and Treatment of Urological Stones, etc. He has published more than 80 academic papers over the past five years, among which, more than 20 are published in core journals. 2012, he was selected as one of the "100 Famous Doctors of China", and was awarded the "China's Top 100 Best Doctors Award". In 2012, he was selected into the list of "Top 100 Chinese Famous Doctors".
Major papers and publications:
Since 1984, she has been engaged in the clinical research and promotion of urology and intracavitary and minimally innovative techniques, including percutaneous nephrolithotomy, ureteroscopic lithotripsy, minimally invasive prostate surgery (TURP, pinprick ablation, holmium laser prostate enucleation, green laser prostate vaporization) and urological laparoscopic surgery. In a large number of clinical practices, he has summarized a set of relatively perfect modern treatment methods for urolithiasis; he has completed more than 10,000 cases of percutaneous nephrolithotripsy and ureteroscopy, which makes him one of the doctors who have completed the most number of such surgeries in China and even in the world; and he has developed and perfected the "Chinese Minimally Invasive Percutaneous Nephrolithotripsy", which has reached a leading position in the country and an advanced level in the world in terms of its surgical effect. In 2006, on behalf of China's urology sector, he attended the U.S. Urology Annual Meeting and the World Conference on Endoluminal Urology, and introduced the method and experience of Chinese Minimally Invasive Percutaneous Nephrolithotripsy (MIPNL), which was fully recognized by scholars at home and abroad, and the technique was gradually promoted at home and abroad, and was named "Chinese MPCNL" by overseas counterparts, improving China's minimally invasive percutaneous nephrolithotripsy. It was named as "Chinese MPCNL" by overseas counterparts, which improved the international influence of urology in China, and "Clinical and Experimental Research on Minimally Invasive Percutaneous Nephrolithotripsy for the Treatment of Upper Upper Urinary Tract Stones" won the second prize of China Medical Science and Technology Award in 2006. He was the first to develop endoluminal technology for the treatment of ureteral stenosis and atresia in China, and has treated more than 700 cases with an overall effective rate of over 80%. He presided over and participated in the research and development of "Li Xun Minimally Invasive Nephroscope" (produced by RICHARD WOLF, Germany), "MCC Luminal Scope Perfusion Pump", "APL Pneumatic Ballistic Lithotripter" and "Cocaine Lithotripter".
Major awards:
Actively promoting the clinical application of endoluminal urological techniques. He presided over the national continuing education program "endoscopic surgical techniques for the treatment of urological diseases" and set up the Luminal Scope Training Center of Peking University Urologist Training Institute in 2004 in cooperation with the Peking University Urologist Training Institute, which is mainly responsible for the national training of urologists in luminal sciences, and has held sixteen national workshops on endoluminal urology techniques in the past ten years and trained more than 1,400 specialists, including more than 1,400 trainees. More than 1400 times, trainees throughout the country and Hong Kong, Macao, Taiwan, Nepal and other regions, has greatly promoted the popularization and development of China's endourology technology, so that the technology is widely used in most areas of the country, so that urinary stone patients can be free from the pain of open surgery, changing the status quo of China's upper urinary tract stone treatment. Position: Chief Physician
Details: Graduated from Guangdong Medical College, Department of Medicine. Now he is the assistant to the president of Guangzhou Medical College Harbor Hospital and the director of major surgery department. He is a member of the Urology Research Committee of the Medical Experts Committee of Guangdong Provincial Old Professors Association and a member of the American Urological Association (AUA). He has been engaged in the clinical, scientific research and teaching work of surgery for more than 20 years, and has rich experience in the diagnosis and treatment of surgical diseases, specializing in the diagnosis, treatment and surgery of urological and male diseases, and specializing in the minimally invasive treatment of urological stones, stenosis deformities and tumors, and prostatic hyperplasia using TV endoscopic surgery. In recent years, she has published more than 10 medical papers at national and provincial levels, and won three scientific and technological progress awards at municipal level. Position: Deputy Chief Physician
Detailed introduction: Director of Urology, Deputy Chief Physician, Master of Science in Intracoelomic Urology, Member and Secretary of the Stone Group of the Urology Branch of the Guangdong Provincial Medical Association, Member of the Urology Society of the Guangzhou Medical Association, Graduated from the Jiangxi Medical College in 1994, and graduated from the Master of Science in Surgery of the Guangzhou Medical College in 2004. He has been engaged in urology for a long time, and is skillful in the diagnosis and treatment of various common and difficult diseases in urology, especially in the minimally invasive techniques for urolithiasis, urinary tract stenosis and prostate diseases. He has independently accomplished minimally invasive percutaneous nephrolithotripsy and ureteroscopy for more than 2,000 cases, and accumulated a large amount of follow-up data of clinical cases, and has presided over and participated in more than three provincial scientific research projects. She has published more than 10 papers in professional journals at home and abroad. Position: Deputy Chief Physician
Detailed introduction: Graduated from the Department of Medicine of Harbin Medical University, she has been engaged in the clinical work of surgery for more than 20 years, and had further training in Beijing Friendship Hospital and Guangdong Provincial People's Hospital. He has accumulated rich clinical experience and is especially good at treating prostate hyperplasia, complex urinary stones, urological tumors, and male diseases, and has published 10 papers.